Literature DB >> 29044265

A comprehensive review of the health perspectives of resveratrol.

Abdur Rauf1, Muhammad Imran, Hafiz Ansar Rasul Suleria, Bashir Ahmad, Dennis G Peters, Mohammad S Mubarak.   

Abstract

Many natural products present in our diet, including flavonoids, can prevent the progression of cancer and other diseases. Resveratrol, a natural polyphenol present in various fruits and vegetables, plays an important role as a therapeutic and chemopreventive agent used in the treatment of various illnesses. It exhibits effects against different types of cancer through different pathways. It additionally exerts antidiabetic, anti-inflammatory, and anti-oxidant effects in a variety of cell types. Furthermore, the cardiovascular protective capacities of resveratrol are associated with multiple molecular targets and may lead to the development of novel therapeutic strategies for atherosclerosis, ischemia/reperfusion, metabolic syndrome, and heart failure. Accordingly, this article presents an overview of recent developments in the use of resveratrol for the prevention and treatment of different diseases along with various mechanisms. In addition, the present review summarizes the most recent literature pertaining to resveratrol as a chemotherapeutic agent against multiple diseases and provides an assessment of the potential of this natural compound as a complementary or alternative medicine.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29044265     DOI: 10.1039/c7fo01300k

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  65 in total

1.  Resveratrol inhibits the migration, invasion and epithelial-mesenchymal transition in liver cancer cells through up- miR-186-5p expression.

Authors:  Feifeng Song; Yiwen Zhang; Zongfu Pan; Qi Zhang; Xixuan Lu; Ping Huang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-10-25

2.  Liensinine Inhibits Cell Growth and Blocks Autophagic Flux in Nonsmall-Cell Lung Cancer.

Authors:  Minghui Chang; Shanshan Ding; Xiaohan Dong; Xiaoling Shang; Yang Li; Li Xie; Xingguo Song; Xianrang Song
Journal:  J Oncol       Date:  2022-07-01       Impact factor: 4.501

Review 3.  Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles.

Authors:  Zhiqiang Deng; Yu Dong; Xiaoting Zhou; Jia-Hong Lu; Zhenyu Yue
Journal:  Acta Pharm Sin B       Date:  2021-12-18       Impact factor: 14.903

4.  Protective effects of pterostilbene against hepatic damage, redox imbalance, mitochondrial dysfunction, and endoplasmic reticulum stress in weanling piglets.

Authors:  Hao Zhang; Yanan Chen; Yue Li; Peilu Jia; Shuli Ji; Yueping Chen; Tian Wang
Journal:  J Anim Sci       Date:  2020-10-01       Impact factor: 3.159

5.  Resveratrol Attenuates Cognitive Deficits of Traumatic Brain Injury by Activating p38 Signaling in the Brain.

Authors:  Zhenhua Shi; Wusi Qiu; Guomin Xiao; Jun Cheng; Ning Zhang
Journal:  Med Sci Monit       Date:  2018-02-22

Review 6.  Therapeutic Potential of Polyphenols in Cardiac Fibrosis.

Authors:  Ning Zhang; Wen-Ying Wei; Ling-Li Li; Can Hu; Qi-Zhu Tang
Journal:  Front Pharmacol       Date:  2018-02-15       Impact factor: 5.810

Review 7.  Therapeutic Effects of Resveratrol on Ischemia-Reperfusion Injury in the Nervous System.

Authors:  Alireza Sarkaki; Mojtaba Rashidi; Mina Ranjbaran; Aram Asareh Zadegan Dezfuli; Zahra Shabaninejad; Ebrahim Behzad; Maryam Adelipour
Journal:  Neurochem Res       Date:  2021-08-07       Impact factor: 3.996

Review 8.  Polyphenols Modulating Effects of PD-L1/PD-1 Checkpoint and EMT-Mediated PD-L1 Overexpression in Breast Cancer.

Authors:  Samia S Messeha; Najla O Zarmouh; Karam F A Soliman
Journal:  Nutrients       Date:  2021-05-19       Impact factor: 5.717

9.  Generation of Stilbene Glycoside with Promising Cell Rejuvenation Activity through Biotransformation by the Entomopathogenic Fungus Beauveria bassiana.

Authors:  Sang Keun Ha; Min Cheol Kang; Seulah Lee; Om Darlami; Dongyun Shin; Inwook Choi; Ki Hyun Kim; Sun Yeou Kim
Journal:  Biomedicines       Date:  2021-05-17

10.  Involvement of Toll-Like Receptor 4 in Decreased Vasopressor Response Following Trauma/Hemorrhagic Shock.

Authors:  Rafi Mazor; Fernando Dos Santos; Joyce B Li; Federico Aletti; Geert Schmid-Schonbein; Erik B Kistler
Journal:  Crit Care Explor       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.